CorVel Co. (NASDAQ:CRVL) Shares Sold by Jane Street Group LLC

Jane Street Group LLC cut its holdings in CorVel Co. (NASDAQ:CRVL) by 22.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 15,920 shares of the business services provider’s stock after selling 4,484 shares during the period. Jane Street Group LLC’s holdings in CorVel were worth $1,771,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of CRVL. Barclays PLC boosted its holdings in shares of CorVel by 380.8% in the 3rd quarter. Barclays PLC now owns 15,977 shares of the business services provider’s stock valued at $5,223,000 after buying an additional 12,654 shares during the period. Franklin Resources Inc. boosted its holdings in shares of CorVel by 9.9% in the 3rd quarter. Franklin Resources Inc. now owns 1,917 shares of the business services provider’s stock valued at $614,000 after buying an additional 173 shares during the period. Ellsworth Advisors LLC boosted its holdings in shares of CorVel by 210.6% in the 4th quarter. Ellsworth Advisors LLC now owns 7,269 shares of the business services provider’s stock valued at $809,000 after buying an additional 4,929 shares during the period. Ballentine Partners LLC boosted its holdings in shares of CorVel by 211.0% in the 4th quarter. Ballentine Partners LLC now owns 2,429 shares of the business services provider’s stock valued at $270,000 after buying an additional 1,648 shares during the period. Finally, Nisa Investment Advisors LLC boosted its holdings in shares of CorVel by 217.1% in the 4th quarter. Nisa Investment Advisors LLC now owns 555 shares of the business services provider’s stock valued at $62,000 after buying an additional 380 shares during the period. 51.36% of the stock is owned by institutional investors and hedge funds.

Insider Activity at CorVel

In related news, Director Alan Hoops sold 10,200 shares of CorVel stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $116.39, for a total value of $1,187,178.00. Following the sale, the director now directly owns 118,213 shares in the company, valued at $13,758,811.07. This trade represents a 7.94% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jeffrey J. Michael sold 16,523 shares of CorVel stock in a transaction dated Wednesday, April 9th. The shares were sold at an average price of $116.99, for a total transaction of $1,933,025.77. Following the completion of the sale, the director now owns 551,787 shares in the company, valued at approximately $64,553,561.13. This represents a 2.91% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 37,200 shares of company stock worth $4,340,250 in the last ninety days. 47.57% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of CorVel from a “hold” rating to a “buy” rating in a report on Friday, April 18th.

CorVel Stock Up 3.3%

Shares of NASDAQ:CRVL opened at $113.71 on Friday. The company has a market cap of $5.84 billion, a PE ratio of 66.89 and a beta of 1.10. The company’s 50-day moving average price is $111.20 and its 200 day moving average price is $116.45. CorVel Co. has a fifty-two week low of $76.53 and a fifty-two week high of $128.61.

About CorVel

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.